PGHL

Procter & Gamble Health Ltd, a mid-cap player in the Pharmaceuticals & Drugs industry, has a market capitalization of Rs 8,690.00 crore. The company's price-to-earnings (P/E) ratio stands at 34.06, slightly above the industry average of 33.18. Over the past year, Procter & Gamble Health has delivered a performance of 7.52%, significantly outperforming the Sensex, which recorded a modest gain of 0.16%. However, recent trends indicate a decline, with the stock down 0.56% in the last trading session, while the Sensex rose by 1.77%. In the short term, the stock has seen a decrease of 0.77% over the past week and 2.09% over the last month. Year-to-date, Procter & Gamble Health is down 1.37%, compared to a 3.82% decline in the Sensex. Longer-term performance shows a 3-year increase of 18.21%, but this is overshadowed by the Sensex's 27.46% rise. Over five years, the stock has gained 16.11%, while the Sensex has surged by 141.20%. Notably, the company has shown a remarkable 439.89% increase over the past decade, compared to the Sensex's 160.25%.